Summary
Cephalosporins generally cause few side effects. Hypersensitivity reactions are less common than with the penicillins and modern studies have presented data contradicting a true cross-reactivity to cephalosporins in patients who have previously reacted to penicillins. Other hypersensitivity reactions to cephalosporins include fever, arthralgia and exanthema observed in two clusters of children who had been given cefaclor.
Nephrotoxicity is not a problem with modern cephalosporins, although slight reductions of renal function have been seen when high doses of ceftazidime were used. Some of the new cephalosporins have a 3- methyl thiotetrazole side-chain, a moiety which confers a risk of reduced synthesis of prothrombin with subsequent risk of bleeding, and of disulfiram-like reactions in patients consuming alcohol following a cephalosporin dose. Other cephalosporins, e.g. ceftriaxone and cefoperazone, are excreted not only via the kidneys but also via the bile. This leads to high biliary concentrations of the active drug, increasing the risk of diarrhoea which may be caused by selection of cytotoxin-producing strains of Clostridium difficile.
Laboratory adverse reactions to cephalosporins are rare. Eosinophilia and thrombocytosis are commonly reported, but are most probably not adverse reactions but signs of healing of the infections treated. Other haematological reactions have been reported in very few patients and have been rapidly reversible when treatment was stopped.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Adhinson, N.F.; Swabb, E.A. and Sugerman, A.A.: Immunology of the monobactam aztreonam. Antimicrobial Agents and Chemotherapy 25: 93 (1984).
Alestig, K.; Carlberg, H.; Nord, C.E. and Trollfors, B.: Effect of cefoperazone on faecal flora. Journal of Antimicrobial Chemotherapy 12: 163 (1983).
Alestig, K.; Trollfors, B.; Andersson, R.; Olaison, L.; Suurküla, M. and Norrby, S.R.: Ceftazidime and renal function. Journal of Antimicrobial Chemotherapy 13: 177 (1984).
Almond, H.R.: Meningococcal infection, unresponsive to cephalothin. New England Journal of Medicine 281: 218 (1969).
Amman, R.; Neftel, K.; Hardmeier, T. and Reinhardt, M.: Cephalosporin-induced cholestatic jaundice. Lancet 2: 336 (1982).
Andrassy, K.; Bechtold, H. and Ritz, E.: Hypoprothrombinemia caused by cephalosporins. Journal of Antimicrobial Chemotherapy 15: 133 (1985).
Aronoff, S.C.; Thomford, W.; Bertino, J.S. and Speck, W.T.: Development of meningitis during therapy with cefamandole. Pediatrics 67: 727 (1981).
Aronsson, B.; Möllby, R. and Nord, C.E.: Antimicrobial Agents and Clostridium difficile in actue enteric disease: epidemiological data from Sweden 1980–1982. Journal of Infectious Diseases 151: 476 (1985).
Arvidsson, A.; Alván, G.; Angelin, B.; Borgå, O. and Nord, C.E.: Ceftriaxone: renal and biliary excretion and effect on the colon microflora. Journal of Antimicrobial Chemotherapy 10: 207 (1982).
Arvidsson, A.; Borgå, Å. and Alván, G.: Renal excretion of cephapirin and cephaloridine: Evidence for a saturable tubular reabsorption. Clinical Pharmacology and Therapeutics 25: 870 (1979).
Ascher, H.; Långdragna exantem hos barn vid behandling med cefaklor. Läkartidningen 83: 411 (1986).
Ballard, J.O.; Barnes, S.G. and Sattler, F.R.: Comparison of the effects of mezlocillin, carbenicillin, and placebo on normal hemostasis. Antimicrobial Agents and Chemotherapy 25: 153 (1984).
Bang, N.U. and Kammer, R.B.: Hematologic complications associated with β-lactam antibiotics. Reviews of Infectious Diseases 5: 5380 (1983).
Barnett, A.S. and Hirshman, C.A.: Anaphylactic reaction to cephapirin during spinal anesthesia. Anesthesia and Analgesia 58: 337 (1979).
Bartlett, J.G.; Chang, T.W.; Gurwith, M.; Gorbach, S.L. and Onderdonk, A.B.: Antibiotic associated pseudomembraneous colitis due to toxin producing clostridia. New England Journal of Medicine 298: 531 (1978).
Barza, M.; The nephrotoxicity of cephalosporins: an overview. Journal of Infectious Diseases 137 (Suppl.): S60 (1978).
Baumgartner, J.D. and Glauser, M.P.: Tolerance study of ceftriaxone compared to that of amoxycillin in patients with pneumonia. Proceedings of the 13th International Congress of Chemotherapy, Vienna (1983).
Bechtel, T.P.; Slaughter, R.L. and Moore, T.D.: Seizures associated with high cerebrospinal fluid concentrations of cefazolin. American Journal of Hospital Pharmacy 37: 271 (1980).
Bechtold, H.; Andrassy, K.; Jähnchen, E.; Koderisch, J.; Koderisch, H. et al.: Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thrombosis and Haemostasis 51: 358 (1984).
Berger, S.; Ernst, E.C. and Barza, M.: Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefa-mandole. Antimicrobial Agents and Chemotherapy 9: 575 (1976).
Berk, D.L.; Verghese, A.; Holtsclaw, S.A. and Smith, J.K.: Enterococcal pneumonia. Occurrence in patients receiving broad-spectrum antibiotic regimens and enteral feeding. American Journal of Medicine 74: 153 (1983).
Bertoni, J.M. and Cho, I.; Severe myoclonus with moxalactam toxicity. Neurology 33,(Suppl. 2): 197 (1983).
Beuning, M.K.; Wold, J.S.; Israel, K.S. and Kammer, R.B.: Disulfiram-like reaction to β-lactams. Journal of the American Medical Association 245: 2027 (1981).
Binns, J.O. and Pankey, G.H.: Meningococcal meningitis treated with cephalothin. A case report. Journal of Louisiana State Medical Society 118: 493 (1966).
Bloch, R.; Luft, F.C.; Rankin, L.I.; Sloan, R.S.; Yum, M.N. and Maxwell, D.R.: Protection from gentamicin nephrotoxicity by cephalothin and carbenicillin. Antimicrobial Agents and Chemotherapy 15: 46 (1979).
Boston Collaborative Drug Surveillance Program: Drug induced convulsion. Lancet 2: 677 (1972).
Branch, D.T. and Gifford, H.: Allergic reactions to transfused cephalothin antibodies. Journal of the American Medical Association 241: 495 (1979).
Brogden, R.N.; Carmine, A.; Heel, R.C.; Morley, P.A.; Speight, T.M. and Avery, G.S.: Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy. Drugs 22: 423 (1981).
Brown, C.E. III; Natelson, E.A.; Bradshaw, M.W.; Alfrey Jr, C.P. and Williams Jr, T.W.: Study of the effects of ticarcillin on blood coagulation and platelet function. Antimicrobial Agents and Chemotherapy 7: 652 (1975).
Capel-Edwards, K.; Atkinson, R.M.; Wheeldon, J.M.; Pratt, D.A.H.; Patterson, G.G.; Harman, I.W. and Foord, R.D.: Effect of the timing of cefuroxime dosage on its protection of rats against gentamicin nephrotoxicity. Infection 8: 41 (1980).
Carlberg, H.; Alestig, K.; Nord, C.E. and Trollfors, B.: Intestinal side effects of cefoperazone. Journal of Antimicrobial Chemotherapy 10: 483 (1982).
Case Records of the Massachusetts General Hospital (Case 49-1975). New England Journal of Medicine 293: 1308 (1975).
Clancy, C.M. and Glew, R.H.: Hypoprothrombinaemia and bleeding associated with cefamandole. Lancet 1: 250 (1983).
Cole, D.R.: Double-blind comparison of phlebitis associated with cefazolin and cephalothin. International Journal of Clinical Pharmacology 14: 75 (1976).
Conly, J.; Ramotar, K.; Rayner, E.; James, M.; Bow, E. et al.: Hypoprothrombinemia and suppression of intestinal flora in febrile granulocytopenic patients. 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Oct. 1983. Abstract No. 1060 (1983).
Delafuente, J.C.; Panush, R.S. and Caldwell, J.R.: Penicillin and cephalosporin immunogenicity in man. Annals of Allergy 43: 337 (1979).
Dellinger, P.; Murphy, T.; Barza, M.; Pinn, M. and Weinstein, L.: Effect of cephalothin on renal cortical concentrations of gentamicin in rats. Antimicrobial Agents and Chemotherapy 9: 587 (1976).
Dodds, M.G. and Foord, R.D.: Enhancement by potent diuretics of renal tubular necrosis induced by cephaloridine. British Journal of Pharmacology 40: 227 (1970).
Drummer, S.; Hauser Jr, W.E. and Remington, J.S.: Antabuselike effect of β-lactam antibiotics. New England Journal of Medicine 303: 1417 (1980).
Elenbaas, R.M.; Ryan, J.L.; Robinson, W.A.; Singsank, M.J.; Harvey, M.J. and Klaasen, C.D.: On the disulfiram-like activity of moxalactam. Clinical Pharmacology and Therapeutics 32: 347 (1982).
Elks, J. Structural formulae and nomenclature of the cephalosporin antibiotics. Drugs 34,(Suppl. 2): 240 (1987).
EORTC International Antimicrobial Therapy Project Group: Three antibiotic regimens in the treatment of infections in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases 137: 24 (1978).
Fanning, W.L.; Gump, D. and Jick, H.: Gentamicin and cephalothin associated rises in blood urea nitrogen. Antimicrobial Agents and Chemotherapy 10: 80 (1976).
Fass, R.J.; Perkins, R.L. and Saslaw, S.: Cephalexin — a new oral cephalosporin: clinical evaluation in sixty-three patients. American Journal of Medical Science 259: 187 (1970).
Fiala, M. and Kaushik, V.: Cephradine in the treatment of infective endocarditis: comparison with cefazolin; in Siegenthaler and Lüthy (Eds) Current Chemotherapy Proceedings of the 10th International Congress on Chemotherapy, Zurich 1977, Vol. 2, p. 867 (American Society for Microbiology, Washington D.C. 1978).
Foord, R.D.: Cephaloridine and the kidney; in Progress in Antimicrobial and Anticancer Chemotherapy. Proceedings of the 6th International Congress of Chemotherapy, Vol. 1, p. 597 (University of Tokyo Press, Tokyo 1970).
Foord, R.D.: Cephaloridine, cephalothin and the kidney. Journal of Antimicrobial Chemotherapy 1 (Suppl.): 119 (1975).
Foster, T.S.; Raehl, C.L. and Wilson, H.D.: Disulfiram-like reaction associated with a parenteral cephalosporin. American Journal of Hospital Pharmacy 37: 858 (1980).
Freij, L.; Hebelka, M. and Seeberg, S.: Meningitis developing during cephalothin therapy of septicaemia. Scandinavian Journal of Infectious Diseases 7: 153 (1975).
Fromtling, R.A. and Gadebusch, H.H.: Ethanol-cephalosporin antibiotic interactions: an animal model for the detection of disulfiram (Antabuse)-like effects. Methods and Findings in Experimental and Clinical Pharmacology 5: 595 (1983).
Gabriel, R.; Foord, R.D. and Joekes, A.M.: Reversible encephalopathy and acute renal failure after cephaloridine. British Medical Journal 4: 283 (1970).
Galanaud, P.; Second, P.; Subtil, E. and Derenne, J.P.: A propos de 4 observations d’agranulocytose au cours de traitements par le cephalothin. Annales de Medicine Interne 127: 579 (1976).
Gardner, M.E.; Fritz, W.L. and Hyland, R.N.: Antibiotic induced seizures. A case attributed to cefazolin and a review of the literature. Drug Intelligence and Clinical Pharmacology 12: 268 (1978).
Gerald, M.D.; Massey, J. and Spadoro, D.C.: Comparative convulsant activity of various penicillins after intracerebral injection in mice. Journal of Pharmacy and Pharmacology 25: 104 (1973).
Gordon, A.J.; Lahon, H. and Phyfferon, M.: A review of cefoperazone sodium in clinical use. Second International Symposium on Cefoperazone Sodium, Hamburg. Academy of Professional Information Services, New York, p.82 (1981).
Gralnick, H.R.; McGiniss, M.; Elton, W. and McCurdy, P.: Haemolytic anemia associated with cephalothin. Journal of the American Medical Association 217: 1193 (1971).
Greul, W.; Mertelsmann, R. and Schassan, H.H.: Hämolytische Anämie und akuten Nieren versagen unter Therapie mit Cephalothin und Furosemid. Medizin und Klinik 71: 1293 (1976).
Haubenstock, A.; Schmidt, P.; Zazgomick, J.; Balcke, P. and Kopsa, H.: Hypoprothrombinaemic bleeding associated with ceftriaxone. Lancet 1: 1215 (1983).
Heinecke, G.; Höffler, U. and Finke, K.: Reversible encephalopathy following cephacetril therapy in high doses in a patient on chronic intermittent hemodialysis. Clinical Nephrology 5: 45 (1976).
Holt, S.; Khan, M.; Orlans, D.A. and Epstein, E.J.: Cephalothin induced neutropenia during the treatment of bacterial endocarditis. Scottish Medical Journal 23: 135 (1978).
Homayouni, H.; Gross, P.A.; Setia, U. and Lynch, T.J.: Leukopenia due to penicillin and cephalosporin homologues. Archives of Internal Medicine 139: 827 (1979).
Hooper, C.A.; Haney, B.B. and Stone, H.H.: Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole. Lancet 1: 39 (1980).
Jeannet, M.; Bloch, A.; Dayer, J.M.; Farquet, J.J.; Girard, J.P. and Cruchaud, A.: Cephalothin induced immune hemolytic anemia. Acta Haematologica (Basel) 55: 109 (1976).
Joehl, R.J.; Rasbach, D.A.; Ballard, J.O.; Weitekamp, M.R. and Sattler, F.R.: Moxalactam. Evaluation of clinical bleedings in patients with abdominal infection. Archives of Surgery 118: 1259 (1983).
Kager, L.; Malmborg, A.S.; Ljungdal, I.; Nord, C.E.; Piper, R. and Dahlgren, P.: Antibiotic prophylaxis with cefoxitin in colo-rec-tal surgery: Effect on the colon microflora and septic complications — a clinical model for prediction of the benefit and risk in using a new antibiotic in prophylaxis. Annals of Surgery 193: 277 (1981).
Kannangara, D.W.; Smith, B. and Cohen, K.: Exfoliative dermatitis during cefoxitin therapy. Archives of Internal Medicine 142: 1031 (1982).
Kaplan, S.L.; Mason, E.O.; Kvernland, S.J.; Louiselle, E.M. and Feigiu, R.D.: Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children. Pediatrics 71: 187 (1983).
Kappas, A.; Shinagawa, N.; Arabi, Y.: Diagnosis of pseudomembranous colitis. British Medical Journal 1: 675 (1978).
van Klingeren, B.: Penicillins, cephalosporins and tetracyclines; in Dukes and Elis (Eds) Side Effects of Drugs Annual 7, p. 271 (Excerpta Medica, Amsterdam 1983).
Kowalsky, S.F. and Wishnoff, F.G.: Evaluation of potential interaction of new cephalosporins with Clinitest. American Journal of Hospital Pharmacy 39: 1499 (1982).
Kroll, M.H. and Elin, R.J.: Mechanism of cefoxitin and cephalothin interference with the Jafle method for creatinine. Clinical Chemistry 29: 2044 (1983).
Lacey, R.W.; Lord, V.L.; Howson, G.L.; Luxton, D.E.A. and Trotter, I.S.: Double-blind study to compare the selection of antibiotic resistance by amoxycillin or cephradine in the commensal flora. Lancet 2: 529 (1983).
Lerner, P.I.: Penetration of cephalothin and lincomycin into the cerebrospinal fluid. American Journal of Medical Sciences 257: 125 (1969).
Lerner, P.I.; Smith, H. and Weinstein, L.: Penicillin neurotoxicity. Annals of the New York Academy of Sciences 145: 310 (1967).
Levison, M.E.; Bran, J.L.; Jepson, J.H. and Kaye, D.: Neutropenia associated with cephapirin therapy. Antimicrobial Agents and Chemotherapy 1: 174 (1972).
Lipsky, J.L.: N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia. Lancet 2: 192 (1983).
Lipsky, J.L.; Lewis, J.C. and Novisk Jr, W.J.: Production of hypoprothrombinaemia by moxalactam and l-methyl-5-thiote-trazole in rats. Antimicrobial Agents and Chemotherapy 25: 380 (1984).
Luft, F.: Cephalosporin and aminoglycoside interactions: clinical and toxicological implications; in Whelton and Neu (Eds) The Aminoglycosides: Microbiology, Clinical Use and Toxicology, p.287 (Marcel Dekker, New York 1982).
Luft, F.C.; Clinical significance of renal changes engendered by aminoglycosides in man. Journal of Antimicrobial Chemotherapy 13,(Suppl. A): 23 (1984).
Malmborg, A.S.; Kager, L. and Nord, C.E.: Effect of moxalactam on bowel flora in patients undergoing colorectal surgery. Abstract No. 27. 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas (1983).
Mangi, R.J.; Kundargi, R.S.; Quintiliani, R. and Andriole, V.T.: Development of meningitis during cephalothin therapy. Annals of Internal Medicine 78: 347 (1973).
Mashimo, K.; Clinical trials with cefoperazone in the field of internal medicine. Clinical Therapeutics 3 (Special Issue): 159 (1980).
Mastelia, G.; Agostini, M.; Barlocco, G. et al.; Alternative antibiotics for treatment of pseudomonas infections in cystic fibrosis. Journal of Antimicrobial Chemotherapy 12,(Suppl. A): 297 (1983).
McArthur, J.E. and Dyment, P.G.: Steven-Johnson Syndrome with hepatitis following therapy with ampicillin and cephalexin. New Zealand Medical Journal 81: 390 (1975).
Milman, N.: Acute interstitial nephritis during treatment with penicillin and cephalothin. Acta Medica Scandinavica 203: 227 (1978).
Moake, J.L.; Butler, C.F.; Howell, G.M.; Cheek, J. and Spruell, M.A.: Hemolysis induced by cefazolin and cephalothin in a patient with penicillin hypersensitivity. Transfusion (Philadelphia) 18: 369 (1978).
Moellering Jr, R.C.; Enterococcal infections in patients treated with moxalactam. Reviews of Infectious Diseases 4 (Suppl.): S708 (1982).
Möllby, R.; Nord, C.E. and Aronsson, B.; Diagnosis of Clostridium difficile-associated enterocolitis in Sweden. Laboratory and epidemiological aspects. Scandinavian Journal of Infectious Diseases 22 (Suppl.): 30 (1980).
Mouallem, R.: Comparative efficacy and safety of cephradine and cephalexin in children. Journal of International Medical Research 4: 265 (1976).
Murray, D.L.; Singer, D.A.; Singer, A.B. and Veldman, J.P.: Cefaclor — a cluster of adverse reactions. New England Journal of Medicine 303: 1003 (1980).
Nemati, C. and Abuelo, J.G.: Cephalosporin induced hypersensitivity nephritis: report of a case caused by cefazolin. Rhode Island Medical Journal 64: 91 (1981).
Neu, H.C.; Cephalosporins in the treatment of meningitis. Drugs 34,(Suppl. 2): 135 (1987).
Neu, H.C. and Prince, A.S.: Interaction between moxalactam and alcohol. Lancet 1: 1422 (1980).
Norrby, R. and Alestig, K.: High frequency of gastrointestinal adverse reactions to single doses of cefoperazone in healthy volunteers. Lancet 2: 1417 (1981).
Norrby, S.R.; Burman, L.Å; Linderholm, H. and Trollfors, B.: Ceftazidime: pharmacokinetics in patients and effects on the renal function. Journal of Antimicrobial Chemotherapy 10: 199 (1982).
Norrby, R.; Foord, R.D.; Price, J.D. and Hedlund, P.; Pharmacokinetics and clinical studies on cefuroxime. Proceedings of the Royal Society of Medicine 70,(Suppl. 9): 25 (1977).
Norrby, R.; Martin, C.M.; van Winzum, C. and Brown, K.R.; The toxicity of cefoxitin in man. Journal of Infection 1,(Suppl. 1): 57 (1979).
Norrby, R.; Stenqvist, K. and Elgefors, B.: Interaction between cephaloridine and furosemide in man. Scandinavian Journal of Infectious Diseases 8: 209 (1976).
O’Brien, M.S. and McLaurin, R.L.: Tolerance of the central nervous system to local instillations of cephalothin. Surgical Forum 19: 435 (1968).
Osborne, J.C.: Hypothrombinemia and bleeding due to cefoperazone. Annals of Internal Medicine 102: 721 (1985).
Oshawa, T. and Furukawa, F.: Neutropenia associated with cefotaxime. Drug Intelligence and Clinical Pharmacy 17: 739 (1983).
Page, J.; Levison, M.E.; Thornhill, T.S. and Kaye, D.: Treatment of soft-tissue infection with cephalexin. Journal of the American Medical Association 211: 1837 (1970).
Pakter, R.L.; Russell, T.R.; Mielke, C.H. and West, D.: Coagulopathy associated with the use of moxalactam. Journal of the American Medical Association 248: 1100 (1982).
Petz, L.D.: Immunologic cross-reactivity between penicillins and cephalosporins: A review. Journal of Infectious Diseases 137: S74 (1978).
Portier, H.; Chalopin, J.M.; Freusz, M. and Tanter, Y.: Interaction between cephalosporins and alcohol. Lancet 2: 263 (1980).
Reddy, J. and Bailey, R.R.: Vitamin K deficiency developing in patients with renal failure treated with cephalosporin antibiotics. New Zealand Medical Journal 92: 378 (1980).
Reeves, D.S. and Davies, A.J.: Antabuse effect with cephalosporins. Lancet 2: 540 (1980).
Rubin, R.N. and Burka, E.R.: Anti-cephalothin antibody and Coombs’ positive hemolytic anemia. Annals of Internal Medicine 86: 64 (1977).
Rymer, W. and Greenlaw, C.W.: Hypoprothrombinaemia associated with cefamandole. Drug Intelligence and Clinical Pharmacy 14: 780 (1980).
Saker, B.M.; Musk, A.W.; Haywood, E.F. and Hurst, P.E.: Reversible toxic psychosis after cephalexin. Medical Journal of Australia 1: 497 (1973).
Saleh, Y. and Tischler, E.: Severe anaphylactic reaction to intravenous cephaloridine in a pregnant patient. Medical Journal of Australia 2: 490 (1974).
Sanders, E.W.; Johnson, J.E. and Taggart, J.G.: Adverse reactions to cephalothin and cephapirin. Uniform occurrence on prolonged intravenous administration of high doses. New England Journal of Medicine 290: 424 (1974).
Saxon, A.; Immediate hypersensitivity reactions to β-lactam antibiotics. Reviews of Infectious Diseases 5,(Suppl. 2): S368 (1983).
Saxon, A.; Hassner, A.; Swabb, E.E.; Wheeler, B. and Adhinson Jr, N.F.: Lack of cross-reactivity between aztreonam, a mon-obactam antibiotic, and penicillin in penicillin allergic subjects. Journal of Infectious Diseases 149: 16 (1984).
Shemonsky, N.K.; Carrioza, J.; Kaye, D. and Levison, M.E.: Double-blind comparison of phlebitis produced by cefazolin versus cephalothin. Antimicrobial Agents and Chemotherapy 7: 481 (1975).
Shibata, K.; Clinical trials in the field of surgery in Japan. Clinical Therapeutics 3 (Special Issue): 173 (1980).
Shindo, H.: Absorption, distribution, excretion and metabolism of cefmetazole. Sankyo, Kenkyusho, Nempo (Japan) 31: 42 (1979).
Silverblatt, F.; Harrison, W.O. and Turck, M.; Nephrotoxicity of cephalosporin antibiotics in experimental animals. Journal of Infectious Diseases 128 (Suppl.): S367 (1973).
Silverblatt, F.; Turck, M. and Bulger, R.: Nephrotoxicity due to cephaloridine: a light- and electron-microscopic study in rabbits. Journal of Infectious Diseases 122: 33 (1970).
Smith, J.W.; Johnson III, J.E. and Cluff, L.E.: Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy. New England Journal of Medicine 274: 998 (1966).
Solley, G.O. and Gleich, G.J.: Penicillin allergy: clinical experience with a battery of skin test reagents. Journal of Allergy and Clinical Immunology 69: 238 (1982).
Somani, P.; Smith, M.R.; Gohara, A. and Kapila, K.; The effects of mezlocillin, ticarcillin, and placebo on blood coagulation and bleeding time in normal volunteers. Journal of Antimicrobial Chemotherapy 11,(Suppl. C): 33 (1983).
Spruill, F.G.; Minette, L.J. and Sturner, W.Q.: Two surgical deaths associated with cephalothin. Journal of the American Medical Association 229: 440 (1974).
Tartas, N.E.; Bullorsky, E.O.; Hevia, J.E. and Sanches Avlos, J.C.: Pancytopenia induced by cephalothin. Journal of the American Medical Association 245: 1148 (1981).
Taylor, R.; Arze, R.; Gokal, R. and Stoddart, J.C.: Cephaloridine encephalopathy. British Medical Journal 283: 409 (1981).
Tollefsen, G.: Neuropsychiatrie sequelae and cephalothin. Journal of Clinical Psychiatry 45: 96 (1984).
Trollfors, B.; Alestig, K. and Norrby, R.: Local and gastrointestinal reactions to intravenously administered cefoxitin and cefuroxime. Scandinavian Journal of Infectious Diseases 11:315 (1979).
Trollfors, B.; Norrby, R.; Kristiansson, K. and Nilsson, N.J.; Effects on renal function of treatment with cefoxitin alone or in combination with furosemide. Scandinavian Journal of Infectious Diseases 13 (Suppl.): 73 (1978).
Trollfors, B.; Norrby, S.R.; Bergmark, J.; Hultberg, B. and Linderholm, H.: Comparative toxicity of gentamicin and cefotetan. Scandinavian Journal of Infectious Diseases 18: 139 (1986).
Trollfors, B.; Suurküla, M.; Price, J.D. and Norrby, R.: Renal function during cefuroxime treatment in patients with pre-existing renal impairment. Journal of Antimicrobial Chemotherapy 6: 665 (1980).
Tune, B.M. and Fravert, D.: Mechanisms of cephalosporin nephrotoxicity: a comparison of cephaloridine and cephaloglycin. Kidney International 18: 591 (1980).
Turck, M.; Andersson, K.N. and Smith, R.H.: Laboratory and clinical evaluation of a new antibiotic — cephalothin. Annals of Internal Medicine 63: 199 (1965).
Ueda, Y.; Saito, A. and Fukuoka, Y.: Interactions of β-lactam antibiotics and antineoplastic agents. Antimicrobial Agents and Chemotherapy 23: 374 (1983).
Ueda, Y.; Saito, A.; Ohmori, M. and Siba, K.: Clinical studies on cefoperazone (T-1551) in the field of internal medicine; in Nelson and Grassi (Eds) Current Chemotherapy and Infectious Diseases, p. 165 (American Society for Microbiology, Washington, DC 1980).
Wade, J.C.; Smith, C.R.; Petty, B.G.; Lipsky, J.J.; Conrad, G.; Ellner, J. and Lietman, P.S.: Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet 2: 604 (1978).
Warrington, R.J.; Simmons, F.E.R.; Ho, H.W. and Gorski, B.A.: Diagnosis of penicillin allergy by skin testing: the Manitoba experience. Canadian Medical Association Journal 118: 787 (1978).
Weitekamp, M.R. and Aber, R.C.: Prolonged bleeding time and bleeding diathesis associated with moxalactam administration. Journal of the American Medical Association 249: 69 (1983).
Welling, P.G.; Dean, S.; Selen, A. and Wise, R.: Probenecid: an unexplained effect on cephalosporin pharmacology. British Journal of Clinical Pharmacology 8: 491 (1979).
Wu, M.J.; Narsete, T.A.; Hussey, J.L.; Weinstein, A.B. and Wen, S.F.: Cephalothin neurotoxicity in renal failure. Annals of Internal Medicine 89: 429 (1978).
Yoshioka, H.; Nambu, H.; Fujita, M. and Uehara, H.: Convulsion following intrathecal cephaloridine. Infection 3: 123 (1975).
Yost, R.L.; Lee, D.J. and O’Leary, J.P.: Convulsions associated with sodium cefazolin: A case report. American Surgeon 43: 417 (1977).
Young, E.J.; Fainstein, V. and Musher, D.M.: Drug induced fever: Cases seen in the evaluation of unexplained fever in a general hospital population. Reviews of Infectious Diseases 4: 69 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Norrby, S.R. Side Effects of Cephalosporins. Drugs 34 (Suppl 2), 105–120 (1987). https://doi.org/10.2165/00003495-198700342-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198700342-00009